San Diego-based Digirad is putting the finishing touches in place for a commercial launch of its solid-state digital gamma camera technology. The firm is taking orders for its lead product, Digirad 2020 TC Imager, and plans to begin commercial shipments
San Diego-based Digirad is putting the finishing touches in place for a commercial launch of its solid-state digital gamma camera technology. The firm is taking orders for its lead product, Digirad 2020 TC Imager, and plans to begin commercial shipments as soon as it completes work on a manufacturing facility to build the cameras.
Digirad received 510(k) clearance last year for 2020 TC Imager, which uses cadmium zinc telluride digital detectors rather than scintillation crystals and photomultiplier tubes (SCAN 6/11/97). Since then, the company has been building a 14,000-square-foot semiconductor fab to manufacture the cameras, according to Karen Klause, president and CEO. Construction of the fab should be finished soon, and 2020 TC Imagers should be shipping some time this year, she said.
At next months Society of Nuclear Medicine meeting in Toronto, Digirad plans to display its latest work on conducting SPECT imaging with its camera using a rotating chair. Because 2020 TC Imagers detector is not housed in a rotating gantry, patients are seated and rotated around the head. Digirad will display cardiac SPECT images collected with the technique, Klause said.
Digirad will also present three papers, the first for the company at a medical conference. One of the papers covers work conducted on scintimammography with Dr. Iraj Khalkhali of Harbor-UCLA Medical Center in Torrance, CA.
Until Digirad is able to start shipping, the company will continue to take orders, which are coming in at a rapid clip from hospitals interested in the firms novel technology, Klause said
We have a long lead time right now (for deliveries) due to the backlog, Klause said. Demand has been much greater than we expected.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.